Growth Metrics

GoodRx Holdings (GDRX) Change in Receivables (2019 - 2026)

GoodRx Holdings' Change in Receivables history spans 7 years, with the latest figure at $30.2 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 99.67% to $30.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $88.0 million, a 3684.01% increase, with the full-year FY2025 number at $88.0 million, up 3684.01% from a year prior.
  • Change in Receivables hit $30.2 million in Q4 2025 for GoodRx Holdings, up from $14.7 million in the prior quarter.
  • Over the last five years, Change in Receivables for GDRX hit a ceiling of $30.2 million in Q4 2025 and a floor of -$31.0 million in Q3 2024.
  • Historically, Change in Receivables has averaged $8.0 million across 5 years, with a median of $7.1 million in 2021.
  • Biggest five-year swings in Change in Receivables: surged 4084.36% in 2021 and later plummeted 1287.59% in 2024.
  • Tracing GDRX's Change in Receivables over 5 years: stood at $19.6 million in 2021, then plummeted by 119.14% to -$3.7 million in 2022, then surged by 699.79% to $22.5 million in 2023, then tumbled by 32.64% to $15.1 million in 2024, then soared by 99.67% to $30.2 million in 2025.
  • Business Quant data shows Change in Receivables for GDRX at $30.2 million in Q4 2025, $14.7 million in Q3 2025, and $28.9 million in Q2 2025.